Hospira Inc. Recall: HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx o
Hospira Inc. Recall: HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx o is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Hospira Inc.; Product: HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LA
| Recalling firm | Hospira Inc. |
|---|---|
| Product | HEXTEND 6% Hetastarch in Lactated Electrolyte Injection, 500 mL, Rx only , MANUFACTURED AND DISTRIBUTED BY HOSPIRA, INC., LAKE FOREST, IL 60045, NDC 0409-1555-54 |
| Reason for recall | Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20121022 |
| Recall number | D-184-2013 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →